NEW YORK (TheStreet) -- The maker of the Invisalign teeth straightening system, Align Technology (ALGN) - Get Report ended Wednesday's trading session down 3.8% to $20.37 after agreeing to acquire dentistry imaging company Cadent for $190 million.

Apollo Global Management

(APO) - Get Report

fell 4.2% to $18.20 following rousing reception of the private-equity firm's long-awaited initial public offering Tuesday. On Wednesday,

Thomson Reuters

releases data highlighting mixed IPO results from Apollo's portfolio companies.

>> Apollo's IPO Gets Warm Reception

Palo Alto, Calif.-based cloud computing application maker

Tibco Software

(TIBX)

rose 1.8% at $26.74 after edging past Wall Street's expectations for its fiscal first-quarter results. While Tibco's performance was ahead of the consensus view, the magnitude of the beat was only 5% vs. a 16% average beat in the previous eight quarters.

>> Tibco Software: After-Hours Trading

Wal-Mart

(WMT) - Get Report

rose 0.2% to $52.36 after a visiting positive territory as judges expressed skepticism about a large class-action lawsuit against the giant retailer over sex discrimination.

Phosphate and potash company

Mosaic

(MOS) - Get Report

ended up 2% to $80.45 ahead of its third-quarter earnings report after the markets close Wednesday.

Chemicals company

DuPont

(DD) - Get Report

added 1.4% to $55.37 after its subsidiary DuPont Denmark extended a $6 billion offer for food ingredients company

Danisco

to April 29 to allow for additional time to obtain regulatory approvals in the European Union and China. So far, shareholders representing a mere 6% stake in Danisco have accepted DuPont's offer, 90% short of the acceptances the buyer would have needed to meet its original offer closing date of April 1.

Drug company

Cephalon

( CEPH) is facing a hostile bid from

Valeant Pharmaceuticals

(VRX)

, which is offering $73 a share, a 24% premium to Cephalon's closing price Tuesday of $58.75.

Cephalon shares surged 28.4% to $75.44 Wednesday.

Shares of Valeant popped 12.8% to $50.08.

>> Valeant Goes Hostile With Cephalon Bid

Investment manager

BlackRock

(BLK) - Get Report

advanced 6.6% to $198.84 as it replaces biotech company

Genzyme

( GENZ) in the S&P 500 after the markets close on Friday.

Discount store chain

Family Dollar

(FDO)

fell 0.3% to $52.25 as investors took profits after the company reported second-quarter earnings of 98 cents a share. The earnings beat narrowly expectations by a penny.

>>Search for Highest Dividends by Rate or Yield

-- Written by Andrea Tse in New York.

>To contact the writer of this article, click here:

Andrea Tse

.

>To follow the writer on Twitter, go to

Andrea Tse

.

>To submit a news tip, send an email to:

tips@thestreet.com

.

Copyright 2010 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.